Early intervention can significantly improve the development and prognosis of T1DM, and effective biomarkers are great significance for the early prediction and diagnosis of T1DM. As a diabetes focused solution provider, Ace Therapeutics has established a multi-functional CRO platform service. We can provide researchers engaged in biomarker development of diabetes with more efficient function analysis.
Biomarkers of T1DM
Some biomarkers can be used for the diagnosis and the prediction of disease risk of T1DM, including genetic markers, pancreatic islets β-cell autoantibodies, T cell biomarkers and emerging biomarkers.
Learn more: diabetes t cell biomarkers